Related by context. Frequent words. (Click for all words.) 71 multicenter Phase 71 Initiate Phase 70 forodesine 69 placebo controlled Phase 68 relapsed refractory multiple myeloma 68 HCV genotypes 68 mg QD 68 Pivotal Phase 68 HCV genotype 67 PRECiSE 67 HCV genotype 1 67 Phase Ib clinical 67 hepatitis C HCV 67 chronic HCV infection 66 Chronic Hepatitis C 66 blinded placebo controlled 66 plus dexamethasone 66 HCV infected 66 phase IIb clinical 66 Engerix B 65 Phase 1b 65 plus gemcitabine 65 Phase 2a trial 65 Pivotal Phase III 65 label multicenter 65 relapsed multiple myeloma 65 Phase 1b clinical 65 PREZISTA r 65 doripenem 65 Phase 1b trial 64 nitazoxanide 64 dose escalation trial 64 elotuzumab 64 metastatic hormone refractory 64 chronic HCV 64 peginterferon alfa 2b 64 Hepatitis C HCV 64 plus methotrexate 64 Pegasys ® 64 Phase 2a clinical 64 R sorafenib tablets 64 Amrubicin 64 Allovectin 7 R 64 phase IIa clinical 64 phase IIa 63 nosocomial pneumonia 63 evaluable patients 63 plus prednisone 63 HER2 positive metastatic breast 63 bendamustine 63 administered subcutaneously 63 liposomal formulation 63 Traficet EN 63 PEG Interferon lambda 63 mRCC 63 Metastatic Melanoma 63 RRMS patients 63 Cethromycin 63 Prulifloxacin 63 INCB# [001] 63 MKC# 63 randomized #:# 63 active comparator 63 relapsing multiple sclerosis 63 dose cohorts 63 APTIVUS 63 double blinded placebo 63 recurrent glioblastoma 63 SCH # 62 celgosivir 62 MORAb 62 randomized multicenter 62 Initiates Phase 62 HGS ETR1 62 transcriptase inhibitor NNRTI 62 peg IFN 62 Phase III Clinical Trial 62 Clevudine 62 mcg dose 62 patients undergoing percutaneous 62 Diabetic Macular Edema 62 peginterferon alfa 62 Pivotal Trial 62 placebo controlled clinical 62 Phase 2b 62 valopicitabine 62 phase 2a 62 refractory multiple myeloma 62 chlorambucil 62 Phase IIb trials 62 KRAS wild 62 Phase 2b study 62 Tesetaxel 62 HIV uninfected 62 Epratuzumab 62 patients evaluable 62 ascending doses 62 mg BID 62 mg kg dose 61 investigational compounds 61 peginterferon alfa 2a